Acetic acid does not improve detection of cancer in Barrett's oesophagus

A trial in 18 Dutch community hospitals found acetic acid chromoendoscopy did not increase the detection rate of neoplasia.

Using acetic acid chromoendoscopy (AAC) did not improve the detection of neoplasia in patients with Barrett's oesophagus. This was found during routine clinical practice surveillance endoscopies.

Researchers conducted a prospective, open label, stepped wedge cluster, randomised trial. The study included 2267 participants across 18 Dutch community hospitals.

The trial assessed the added value of AAC for detecting dysplasia and oesophageal adenocarcinoma. Neoplasia detection rate was the primary endpoint. This was defined as the percentage of participants with low grade dysplasia, high grade dysplasia, and oesophageal adenocarcinoma in any biopsy.

Of the 2267 participants, 1438 (63%) were allocated to surveillance without AAC. 829 (37%) were allocated to AAC. AAC was applied in 679 (82%) allocated participants.

Overall, neoplasia was diagnosed in 163 (7.2%) participants. This included 111 (4.9%) low grade dysplasia, 30 (1.3%) high grade dysplasia, and 22 (1.0%) oesophageal adenocarcinoma.

The neoplasia detection rate with AAC was 7.4% (50/679) compared to 7.1% (113/1588) without AAC. The targeted neoplasia detection rate was 2.1% (14/679) with AAC versus 1.8% (29/1588) without AAC.

Key facts

  • AAC use did not increase the neoplasia detection rate.
  • Suspected lesions were detected in 95 (14.0%) participants receiving AAC versus 101 (6.4%) without AAC.
  • The study included 2267 participants in 18 Dutch community hospitals.

All sections

Edition